Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (311-320 of 547) with videos related to

Pageof 55
Sort By:
Plos One|January 21, 2017
Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant NeuroblastomaMichael K Kiessling, Alessandra Curioni-Fontecedro, Panagiotis Samaras, et al.
Swiss Medical Weekly|August 13, 2024
Detection rate of colorectal cancer by routine colonoscopy is comparable in patients aged 45-49 and 50-54 yearsCarla Ammann, Rina Maqkaj, Marcel Andre Schneider, et al.
BMJ Open|December 29, 2020
Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case-control studyLeolin Katsidzira, Wisdom F Mudombi, Rudo Makunike-Mutasa, et al.
European Journal of Gastroenterology & Hepatology|August 3, 2016
Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experienceJonas Bontà, Jonas Zeitz, Pascal Frei, et al.
World Journal of Gastroenterology|July 4, 2009
Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel diseaseCarsten Gnewuch, Gerhard Liebisch, Thomas Langmann, et al.
Inflammatory Bowel Diseases|October 12, 2011
Systematic assessment of factors influencing preferences of Crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL)Stephan R Vavricka, Nicoletta Bentele, Michael Scharl, et al.
Nature Communications|June 13, 2023
Temperature-triggered in situ forming lipid mesophase gel for local treatment of ulcerative colitisMarianna Carone, Marianne R Spalinger, Robert A Gaultney, et al.
Inflammatory Intestinal Diseases|September 28, 2019
Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and MorePhilipp Schreiner, Markus F Neurath, Siew C Ng, et al.
Plos One|July 3, 2018
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patientsBahtiyar Yilmaz, Marianne R Spalinger, Luc Biedermann, et al.
Journal of Crohn'S & Colitis|March 23, 2013
Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinionGerhard Rogler, Xavier Aldeguer, Wolfgang Kruis, et al.
Pageof 55

Showing results (311-320 of 547) with videos related to

Sort By:
Pageof 55
Plos One|January 21, 2017
Correction: Targeting the mTOR Complex by Everolimus in NRAS Mutant NeuroblastomaMichael K Kiessling, Alessandra Curioni-Fontecedro, Panagiotis Samaras, et al.
Swiss Medical Weekly|August 13, 2024
Detection rate of colorectal cancer by routine colonoscopy is comparable in patients aged 45-49 and 50-54 yearsCarla Ammann, Rina Maqkaj, Marcel Andre Schneider, et al.
BMJ Open|December 29, 2020
Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case-control studyLeolin Katsidzira, Wisdom F Mudombi, Rudo Makunike-Mutasa, et al.
European Journal of Gastroenterology & Hepatology|August 3, 2016
Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experienceJonas Bontà, Jonas Zeitz, Pascal Frei, et al.
World Journal of Gastroenterology|July 4, 2009
Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel diseaseCarsten Gnewuch, Gerhard Liebisch, Thomas Langmann, et al.
Inflammatory Bowel Diseases|October 12, 2011
Systematic assessment of factors influencing preferences of Crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL)Stephan R Vavricka, Nicoletta Bentele, Michael Scharl, et al.
Nature Communications|June 13, 2023
Temperature-triggered in situ forming lipid mesophase gel for local treatment of ulcerative colitisMarianna Carone, Marianne R Spalinger, Robert A Gaultney, et al.
Inflammatory Intestinal Diseases|September 28, 2019
Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and MorePhilipp Schreiner, Markus F Neurath, Siew C Ng, et al.
Plos One|July 3, 2018
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patientsBahtiyar Yilmaz, Marianne R Spalinger, Luc Biedermann, et al.
Journal of Crohn'S & Colitis|March 23, 2013
Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinionGerhard Rogler, Xavier Aldeguer, Wolfgang Kruis, et al.
Pageof 55